FREE SHIPPING over $40
OVER 9000 FIVE-STAR REVIEWS
5% OFF ALL SUBSCRIPTIONS
100% HAPPINESS GUARANTEE
Analyze Diet
0
Home / Equine Research Bank / J Vet Intern Med / Hypoglycin A Concentrations in Maple Tree Species in the Net...
Journal of veterinary internal medicine2016; 30(3); 880-884; doi: 10.1111/jvim.13927

Hypoglycin A Concentrations in Maple Tree Species in the Netherlands and the Occurrence of Atypical Myopathy in Horses.

Abstract: Atypical myopathy (AM) in horses is caused by the plant toxin hypoglycin A, which in Europe typically is found in the sycamore maple tree (Acer pseudoplatanus). Owners are concerned about whether their horses are in danger if they graze near maple trees. Objective: To measure hypoglycin A in the most common maple tree species in the Netherlands, and to determine whether concentration of toxin is a predictor of AM in horses. Methods: A total of 278 samples of maple tree leaves, sprouts, and seeds were classified by species. Mean concentrations of hypoglycin A were compared for the type of sample, the season and the occurrence of AM in the pasture (non-AM versus AM). Statistical analysis was performed using generalized a linear model (SPPS22). Results: Almost all Acer pseudoplatanus samples contained hypoglycin A, with concentrations differing significantly among sources (P < .001). Concentrations were significantly higher in seeds from the AM group than in seeds from the non-AM group (856 ± 677 and 456 ± 358 mg/kg, respectively; P = .039). In sprouts and leaves this was not the case. Acer platanoides and Acer campestre samples did not contain detectable concentrations of hypoglycin A. Conclusions: Acer platanoides and campestre seem to be safe around paddocks and pastures, whereas almost all Acer pseudoplatanus samples contained hypoglycin A. In all AM cases, Acer pseudoplatanus was found. Despite significantly higher concentration of hypoglycin A in seeds of pastures where AM has occurred, individual prediction of AM cannot be made by measuring these concentrations because of the high standard deviation.
Copyright © 2016 The Authors. Journal of Veterinary Internal Medicine published by Wiley Periodicals, Inc. on behalf of the American College of Veterinary Internal Medicine.
Get Full Text
Publication Date: 2016-03-20 PubMed ID: 26995161PubMed Central: PMC4913566DOI: 10.1111/jvim.13927Google Scholar: Lookup
The Equine Research Bank provides access to a large database of publicly available scientific literature. Inclusion in the Research Bank does not imply endorsement of study methods or findings by Mad Barn.
LinkedInCopy
  • Journal Article

Summary

This research summary has been generated with artificial intelligence and may contain errors and omissions. Refer to the original study to confirm details provided. Submit correction.

The study investigates the link between atypical myopathy (AM) in horses and the toxin hypoglycin A found in certain maple tree species in the Netherlands. The research examines the toxin’s concentration across different tree species, and if this concentration can predict the occurrence of the AM disease.

Research Objective

The study’s main goal is to measure hypoglycin A levels in the most common maple species in the Netherlands, and establish if this toxin’s concentration can act as a telltale sign of Atypical Myopathy in horses.

Methodology

  • A total of 278 samples consisting of maple tree leaves, sprouts, and seeds were carefully classified by species.
  • The average hypoglycin A concentrations were compared according to the sample type, the season, and the presence—or lack thereof—of AM in the pasture.
  • Statistical analysis was carried out using a generalized linear model (SPPS22).

Results

  • Almost all samples from Acer pseudoplatanus trees contained some amount of hypoglycin A, and concentrations significantly varied among sources.
  • Seeds from pastures with AM had notably higher concentrations of the toxin when compared to those from non-AM pastures. Sprouts and leaves, however, did not exhibit this difference.
  • Samples from Acer platanoides and Acer campestre did not have detectable levels of hypoglycin A.

Conclusion

  • Acer platanoides and Acer campestre tree species appear safe for horses and can be around paddocks and pastures as they do not contain detectable hypoglycin A levels.
  • Almost all Acer pseudoplatanus samples contained some degree of hypoglycin A, and all AM cases were found to be associated with this tree species.
  • Although pastures with AM featured significantly higher hypoglycin A concentrations in their seeds, the broad standard deviation means that predicting individual instances of AM through toxin measurement isn’t feasible.

Although the research provides useful insights on which tree species are safer for horses, it underscores that the measured hypoglycin A concentrations can’t be a reliable predictor of individual AM cases due to the high standard deviation.

Cite This Article

APA
Westermann CM, van Leeuwen R, van Raamsdonk LW, Mol HG. (2016). Hypoglycin A Concentrations in Maple Tree Species in the Netherlands and the Occurrence of Atypical Myopathy in Horses. J Vet Intern Med, 30(3), 880-884. https://doi.org/10.1111/jvim.13927

Publication

Journal of veterinary internal medicine
ISSN: 1939-1676
NlmUniqueID: 8708660
Country: United States
Language: English
Volume: 30
Issue: 3
Pages: 880-884

Researcher Affiliations

Westermann, C M
  • Department of Equine Sciences, Faculty of Veterinary Medicine, Utrecht University, Utrecht, the Netherlands.
van Leeuwen, R
  • RIKILT-Wageningen UR, Wageningen, the Netherlands.
van Raamsdonk, L W D
  • RIKILT-Wageningen UR, Wageningen, the Netherlands.
Mol, H G J
  • RIKILT-Wageningen UR, Wageningen, the Netherlands.

MeSH Terms

  • Acer / chemistry
  • Animals
  • Horse Diseases / chemically induced
  • Horse Diseases / epidemiology
  • Horses
  • Hypoglycins / analysis
  • Hypoglycins / toxicity
  • Muscular Diseases / chemically induced
  • Muscular Diseases / epidemiology
  • Muscular Diseases / veterinary
  • Netherlands / epidemiology
  • Plant Leaves / chemistry
  • Plant Poisoning / veterinary
  • Seeds / chemistry

References

This article includes 21 references
  1. Bowen JN, Craig JF. Myoglobinuria in horses. Vet Rec 1942;35:354.
  2. Brandt K, Hinrichs U, Glitz F. Atypical myoglobinuria in grazing horses. Pferdeheilkunde 1997;13:27–34.
  3. Westermann CM, de Sain‐van der Velden MG, van der Kolk JH. Equine biochemical multiple acyl‐Coa dehydrogenase deficiency (MADD) as a cause of rhabdomyolysis. Mol Genet Metab 2007;91:362–369.
    pubmed: 17540595
  4. Westermann CM, Dorland L, Votion DM. Acquired multiple acyl‐Coa dehydrogenase deficiency in 10 horses with atypical myopathy. Neuromuscul Disord 2008;18:355–364.
    pubmed: 18406615
  5. Votion DM, Linden A, Delguste C. Atypical myopathy in grazing horses: a first exploratory data analysis. Vet J 2009;180:77–87.
    pubmed: 18396430
  6. Votion D‐, Linden A, Saegerman C. History and clinical features of atypical myopathy in horses in Belgium (2000–2005). J Vet Intern Med 2007;21:1380–1391.
    pubmed: 18196750
  7. Van Galen G, Amory H, Busschers E. European outbreak of atypical myopathy in the autumn 2009. J Vet Emerg Crit Care (San Antonio) 2010;20:528–532.
    pubmed: 20955305
  8. van Galen G, Marcillaud Pitel C, Saegerman C. European outbreaks of atypical myopathy in grazing equids (2006–2009): spatiotemporal distribution, history and clinical features. Equine Vet J 2012;44:614–620.
    pubmed: 22448904
  9. van Galen G, Saegerman C, Marcillaud Pitel C. European outbreaks of atypical myopathy in grazing horses (2006–2009): determination of indicators for risk and prognostic factors. Equine Vet J 2012;44:621–625.
    pubmed: 22413891
  10. Sas AM, van der Kolk JH, Dank M, Westermann CM. Atypical myopathy: a review and description of the outbreak in the Netherlands during autumn 2009 and spring 2010. Tijdschr Diergeneeskd 2012;137:514–521.
    pubmed: 22930982
  11. Cassart D, Baise E, Cherel Y. Morphological alterations in oxidative muscles and mitochondrial structure associated with equine atypical myopathy. Equine Vet J 2007;39:26–32.
    pubmed: 17228591
  12. Finno CJ, Valberg SJ, Wünschmann A, Murphy MJ. Seasonal pasture myopathy in horses in the Midwestern United States: 14 cases (1998–2005). J Am Vet Med Assoc 2006;229:1134–1141.
    pubmed: 17014363
  13. van der Kolk JH, Wijnberg ID, Westermann CM. Equine acquired multiple acyl‐Coa dehydrogenase deficiency (MADD) in 14 horses associated with ingestion of maple leaves (Acer Pseudoplatanus) covered with European tar spot (Rhytisma Acerinum). Mol Genet Metab 2010;101:289–291.
    pubmed: 20655779
  14. Sponseller BT, Valberg SJ, Schultz NE. Equine multiple acyl‐Coa dehydrogenase deficiency (MADD) associated with seasonal pasture myopathy in the Midwestern United States. J Vet Intern Med 2012;26:1012–1018.
    pubmed: 22708588
  15. Valberg SJ, Sponseller BT, Hegeman AD. Seasonal pasture myopathy/atypical myopathy in North America associated with ingestion of Hypoglycin A within seeds of the box elder tree. Equine Vet J 2013;45:419–426.
    pubmed: 23167695
  16. Votion DM, van Galen G, Sweetman L. Identification of methylenecyclopropyl acetic acid in serum of European horses with atypical myopathy. Equine Vet J 2014;46:146–149.
    pubmed: 23773055
  17. Unger L, Nicholson A, Jewitt EM. Hypoglycin A concentrations in seeds of acer pseudoplatanus trees growing on atypical myopathy‐affected and control pastures. J Vet Intern Med 2014;28:1289–1293.
    pmc: PMC4857957pubmed: 24863395
  18. Fowden L, Pratt H. Cyclopropylamino acids of the genus Acer: distribution and biosynthesis. Phytochemistry 1973;12:1677–1681.
  19. Finno CJ, Spier SJ. Prevention and treatment of equine atypical myopathy – an acute, highly fatal disease of unknown etiology. Vet J 2008;178:163–164.
    pubmed: 18554966
  20. Gillman JH, Hegeman AD, Sharp RG. Clarifying the role of maples in atypical myopathy. Equine Vet J 2014;46:135–136.
    pubmed: 24548373
  21. Gonzalez‐Medina S. Update on the cause of equine atypical myopathy. Vet Rec 2015;176:143–145.
    pubmed: 25655543

Citations

This article has been cited 16 times.
  1. González-Medina S, Hyde C, Chang YM, Piercy RJ. Assessment of tree-associated atypical myopathy risk factors in Acer pseudoplatanus (sycamore) seeds and leaves. Equine Vet J 2025 Nov;57(6):1656-1665.
    doi: 10.1111/evj.14475pubmed: 39865342google scholar: lookup
  2. Wouters CP, Klein B, Price N, Boemer F, Voz ML, Votion DM. A Zebrafish Embryo Model to Screen Potential Therapeutic Compounds in Sapindaceae Poisoning. Molecules 2024 Oct 19;29(20).
    doi: 10.3390/molecules29204954pubmed: 39459322google scholar: lookup
  3. Aboling S. Do Poisonous Plants in Pastures Communicate Their Toxicity? Meta-Study and Evaluation of Poisoning Cases in Central Europe. Animals (Basel) 2023 Dec 8;13(24).
    doi: 10.3390/ani13243795pubmed: 38136831google scholar: lookup
  4. Sander J, Terhardt M, Janzen N, Renaud B, Kruse CJ, François AC, Wouters CP, Boemer F, Votion DM. Tissue Specific Distribution and Activation of Sapindaceae Toxins in Horses Suffering from Atypical Myopathy. Animals (Basel) 2023 Jul 26;13(15).
    doi: 10.3390/ani13152410pubmed: 37570219google scholar: lookup
  5. El-Khatib AH, Lamp J, Weigel S. A sensitive LC-MS/MS method for the quantification of the plant toxins hypoglycin A and methylenecyclopropylglycine and their metabolites in cow's milk and urine and application to farm milk samples from Germany. Anal Bioanal Chem 2023 Apr;415(10):1933-1942.
    doi: 10.1007/s00216-023-04607-9pubmed: 36877265google scholar: lookup
  6. El-Khatib AH, Engel AM, Weigel S. Co-Occurrence of Hypoglycin A and Hypoglycin B in Sycamore and Box Elder Maple Proved by LC-MS/MS and LC-HR-MS. Toxins (Basel) 2022 Sep 1;14(9).
    doi: 10.3390/toxins14090608pubmed: 36136546google scholar: lookup
  7. Renaud B, Kruse CJ, François AC, Grund L, Bunert C, Brisson L, Boemer F, Gault G, Ghislain B, Petitjean T, Gustin P, Votion DM. Acer pseudoplatanus: A Potential Risk of Poisoning for Several Herbivore Species. Toxins (Basel) 2022 Jul 26;14(8).
    doi: 10.3390/toxins14080512pubmed: 35893754google scholar: lookup
  8. Kruse CJ, Stern D, Mouithys-Mickalad A, Niesten A, Art T, Lemieux H, Votion DM. In Vitro Assays for the Assessment of Impaired Mitochondrial Bioenergetics in Equine Atypical Myopathy. Life (Basel) 2021 Jul 20;11(7).
    doi: 10.3390/life11070719pubmed: 34357091google scholar: lookup
  9. Hirz M, Gregersen HA, Sander J, Votion DM, Schänzer A, Köhler K, Herden C. Atypical myopathy in 2 Bactrian camels. J Vet Diagn Invest 2021 Sep;33(5):961-965.
    doi: 10.1177/10406387211020721pubmed: 34092152google scholar: lookup
  10. González-Medina S, Bevin W, Alzola-Domingo R, Chang YM, Piercy RJ. Hypoglycin A absorption in sheep without concurrent clinical or biochemical evidence of disease. J Vet Intern Med 2021 Mar;35(2):1170-1176.
    doi: 10.1111/jvim.16077pubmed: 33675130google scholar: lookup
  11. Sander J, Terhardt M, Janzen N. Detection of maple toxins in mare's milk. J Vet Intern Med 2021 Jan;35(1):606-609.
    doi: 10.1111/jvim.16004pubmed: 33336854google scholar: lookup
  12. Votion DM, François AC, Kruse C, Renaud B, Farinelle A, Bouquieaux MC, Marcillaud-Pitel C, Gustin P. Answers to the Frequently Asked Questions Regarding Horse Feeding and Management Practices to Reduce the Risk of Atypical Myopathy. Animals (Basel) 2020 Feb 24;10(2).
    doi: 10.3390/ani10020365pubmed: 32102384google scholar: lookup
  13. Karlíková R, Široká J, Mech M, Friedecký D, Janečková H, Mádrová L, Hrdinová F, Drábková Z, Dobešová O, Adam T, Jahn P. Newborn foal with atypical myopathy. J Vet Intern Med 2018 Sep;32(5):1768-1772.
    doi: 10.1111/jvim.15236pubmed: 30216546google scholar: lookup
  14. Barnaby AG, Clarke J, Warren D, Duffus K. Free Radical Scavenging Capacity, Carotenoid Content, and NMR Characterization of Blighia sapida Aril Oil. J Lipids 2018;2018:1762342.
    doi: 10.1155/2018/1762342pubmed: 30186635google scholar: lookup
  15. González Medina S, Hyde C, Lovera I, Piercy RJ. Detection of equine atypical myopathy-associated hypoglycin A in plant material: Optimisation and validation of a novel LC-MS based method without derivatisation. PLoS One 2018;13(7):e0199521.
    doi: 10.1371/journal.pone.0199521pubmed: 29969503google scholar: lookup
  16. Boemer F, Detilleux J, Cello C, Amory H, Marcillaud-Pitel C, Richard E, van Galen G, van Loon G, Lefère L, Votion DM. Acylcarnitines profile best predicts survival in horses with atypical myopathy. PLoS One 2017;12(8):e0182761.
    doi: 10.1371/journal.pone.0182761pubmed: 28846683google scholar: lookup
Subscribe to our newsletter
Join 99,357 horse owners like you who receive our email updates on horse health and nutrition.